BackgroundA global shift to bivalent mRNA vaccines is ongoing to counterbalance diminishing monovalent vaccine effectiveness (VE) due to the evolution of SARS-CoV-2 variants, yet substantial variation in the bivalent VE exists across studies and a complete picture is lacking.
MethodsWe searched papers evaluating SARS-CoV-2 bivalent mRNA vaccines on PubMed, Web of... Show more